AGAT Laboratories’ Post

Another development CatSci Ltd made in 2023 was when we updated our Digital Lab Walkthrough. With this digital tool, you are invited to take a virtual tour of our state-of-the-art Cardiff facilities.  Listen to some of our experts, including Dr Ross Burn (CEO), Dr Simon Tyler (CCO), Robert Dennehy PhD FRSC (Director of Material Sciences), Dr Nigel Richardson (Director of New Modalities), Dr Sam Whitmarsh (Director of Analytical Science and Digital Transformation), Dr Dan Smith (Director of Operations), Dr Jo Hansed (née Sampson) (Principal Scientist), Dr Beth Hindley-Rees (Group Analytical Lead) and Dr Vargini Thangavadivale (Principal Scientist) talk about our cutting-edge facilities and unique ways of working. Plus, wherever you are in the world, you can explore our world-class Chemical Development, High Potency, Material Science and Analytical laboratories and learn more about our capabilities, including our brand-new Oligonucleotides function. Take the tour here: https://lnkd.in/eP9spCmY  #ExcellenceInMedicinesDevelopment #ProudToBeCatSci #LabTour #Laboratories #ChemicalDevelopment #MaterialScience #HighPotencyDevelopment #HPAPI #Oligonucleotides #AnalyticalScience #DigitalLabTour #ProcessChemistry #PharmaceuticalIndustry #Milestones

DON'T MISS TOMORROW'S COURSE LAST CHANCE TO BOOK YOUR SEAT FOR THIS 60 MINUTE COURSE STARTS AT 15.30 IST , 10.00 AM GMT, 11.00 AM CET, 5.00 AM EST Course Title: PUPSIT – Points to Consider Course Instructor: Maik Jornitz Founder and Principal Consultant of BioProcess Resources LLC. With the publication of the new Annex 1, pre-use post sterilization integrity testing (PUPSIT) of the sterile filter in front of a filling system has been once again emphasized. However, different to previous versions, the regulators added a sentence that it may not be always possible to perform such test and risk assessment tools shall be utilized to find an alternative. PDA and BioPhorum’s task forces on PUPSIT have created a wealth of scientific data; incl. masking studies, data mining, points to consider implementing the test and risk assessment from filter production to end-use. This webinar discusses the pros and cons of PUPSIT as well as the task force findings. Maik Jornitz, Founder and Principal Consultant of BioProcess Resources, is a 35-year veteran of the industry. He is a highly experienced in single-use bioprocesses, aseptic processing, and a subject matter expert in sterilizing grade filtration and filter integrity testing. He has published multiple books, book chapters and over 100 scientific papers on various bioprocessing and facility design topics. He is the former Chair of the PDA Board of Directors and Science Advisory Board, and member of multiple PDA Task Forces, including the EU Annex I response team. He is working member of ASTM E55, an advisory board member of the Biotechnology Industry Council, ICAV, Bondwell and board member of DIANT Pharma and Sunflower Therapeutics. As a faculty member of various training activities, including PDA TRI, he trains members of the industry and regulatory authorities frequently. In his previous roles, he was the CEO of G-CON for 10 years, he worked 26 years for Sartorius, with his last role being the SVP for Global Product and Marketing Management Bioprocess. He received his M.Eng. in Bioengineering at the University of Applied Sciences in Hamburg, Germany and accomplished the PED program at IMD Business School in Lausanne, Switzerland. #Sterilization #sterility #IntegrityTesting #asepticprocessing #RiskAssessment #IntegrityTest #PUPSIT #Annex1 #GMP #pharmaceuticalprocessing #SterilizingGradeFiltration #SterileFilters #FillingSytems #Sterile #Bioprocessing #Biotechnology #Technicians #LaboratoryManagers #ProcessSupervisor #NewAnnex1 #validation #qualityassurance #ProcessDevelopment #AdavanceAsepticProcessing #sterileprocessing #sterility #Biotechnology #Biologics #BiopharmaAsia #BiopharmaWebinars #biotech

BOOK YOUR SEAT FOR THIS 60 MINUTE COURSE THIS THURSDAY NOVEMBER 9TH STARTS AT 15.30 IST , 10.00 AM GMT, 11.00 AM CET, 5.00 AM EST Course Title: PUPSIT – Points to Consider Course Instructor: Maik Jornitz Founder and Principal Consultant of BioProcess Resources LLC. With the publication of the new Annex 1, pre-use post sterilization integrity testing (PUPSIT) of the sterile filter in front of a filling system has been once again emphasized. However, different to previous versions, the regulators added a sentence that it may not be always possible to perform such test and risk assessment tools shall be utilized to find an alternative. PDA and BioPhorum’s task forces on PUPSIT have created a wealth of scientific data; incl. masking studies, data mining, points to consider implementing the test and risk assessment from filter production to end-use. This webinar discusses the pros and cons of PUPSIT as well as the task force findings. Maik Jornitz, Founder and Principal Consultant of BioProcess Resources, is a 35-year veteran of the industry. He is a highly experienced in single-use bioprocesses, aseptic processing, and a subject matter expert in sterilizing grade filtration and filter integrity testing. He has published multiple books, book chapters and over 100 scientific papers on various bioprocessing and facility design topics. He is the former Chair of the PDA Board of Directors and Science Advisory Board, and member of multiple PDA Task Forces, including the EU Annex I response team. He is working member of ASTM E55, an advisory board member of the Biotechnology Industry Council, ICAV, Bondwell and board member of DIANT Pharma and Sunflower Therapeutics. As a faculty member of various training activities, including PDA TRI, he trains members of the industry and regulatory authorities frequently. In his previous roles, he was the CEO of G-CON for 10 years, he worked 26 years for Sartorius, with his last role being the SVP for Global Product and Marketing Management Bioprocess. He received his M.Eng. in Bioengineering at the University of Applied Sciences in Hamburg, Germany and accomplished the PED program at IMD Business School in Lausanne, Switzerland. #Sterilization #sterility #IntegrityTesting #asepticprocessing #RiskAssessment #IntegrityTest #PUPSIT #Annex1 #GMP #pharmaceuticalprocessing #SterilizingGradeFiltration #SterileFilters #FillingSytems #Sterile #Bioprocessing #Biotechnology #Operators #Technicians #LaboratoryManagers #ProcessSupervisors #BiopharmaCourses PDA - Parenteral Drug Association BioPhorum #NewAnnex1 #Validation #qualityassurance #ProcessDevelopment #AdavanceAsepticProcessing #sterileprocessing #sterility #Biotechnology #Biologics #BiopharmaAsia #BiopharmaWebinars https://lnkd.in/ePhtZq-t

DON'T MISS THIS LAST CHANCE TO BOOK YOUR SEAT FOR THIS 60 MINUTE COURSE THIS THURSDAY NOVEMBER 9TH STARTS AT 15.30 IST , 10.00 AM GMT, 11.00 AM CET, 5.00 AM EST Course Title: PUPSIT – Points to Consider Course Instructor: Maik Jornitz Founder and Principal Consultant of BioProcess Resources LLC. With the publication of the new Annex 1, pre-use post sterilization integrity testing (PUPSIT) of the sterile filter in front of a filling system has been once again emphasized. However, different to previous versions, the regulators added a sentence that it may not be always possible to perform such test and risk assessment tools shall be utilized to find an alternative. PDA and BioPhorum’s task forces on PUPSIT have created a wealth of scientific data; incl. masking studies, data mining, points to consider implementing the test and risk assessment from filter production to end-use. This webinar discusses the pros and cons of PUPSIT as well as the task force findings. Maik Jornitz, Founder and Principal Consultant of BioProcess Resources, is a 35-year veteran of the industry. He is a highly experienced in single-use bioprocesses, aseptic processing, and a subject matter expert in sterilizing grade filtration and filter integrity testing. He has published multiple books, book chapters and over 100 scientific papers on various bioprocessing and facility design topics. He is the former Chair of the PDA Board of Directors and Science Advisory Board, and member of multiple PDA Task Forces, including the EU Annex I response team. He is working member of ASTM E55, an advisory board member of the Biotechnology Industry Council, ICAV, Bondwell and board member of DIANT Pharma and Sunflower Therapeutics. As a faculty member of various training activities, including PDA TRI, he trains members of the industry and regulatory authorities frequently. In his previous roles, he was the CEO of G-CON for 10 years, he worked 26 years for Sartorius, with his last role being the SVP for Global Product and Marketing Management Bioprocess. He received his M.Eng. in Bioengineering at the University of Applied Sciences in Hamburg, Germany and accomplished the PED program at IMD Business School in Lausanne, Switzerland. #Sterilization #sterility #IntegrityTesting #asepticprocessing #RiskAssessment #IntegrityTest #PUPSIT #Annex1 #GMP #pharmaceuticalprocessing #SterilizingGradeFiltration #SterileFilters #FillingSytems #Sterile #Bioprocessing #Biotechnology #Operators #Technicians #LaboratoryManagers #ProcessSupervisors #BiopharmaCourses PDA - Parenteral Drug Association BioPhorum #NewAnnex1 #Validation #qualityassurance #ProcessDevelopment #AdavanceAsepticProcessing #sterileprocessing #sterility #Biotechnology #Biologics #BiopharmaAsia #BiopharmaWebinars #biotech https://lnkd.in/ePhtZq-t

BOOK YOUR SEAT FOR THIS 60 MINUTE COURSE ON NOVEMBER 9TH STARTS AT 15.30 IST , 10.00 AM GMT, 11.00 AM CET, 5.00 AM EST PUPSIT – Points to Consider With the publication of the new Annex 1, pre-use post sterilization integrity testing (PUPSIT) of the sterile filter in front of a filling system has been once again emphasized. However, different to previous versions, the regulators added a sentence that it may not be always possible to perform such test and risk assessment tools shall be utilized to find an alternative. PDA and BioPhorum’s task forces on PUPSIT have created a wealth of scientific data; incl. masking studies, data mining, points to consider implementing the test and risk assessment from filter production to end-use. This webinar discusses the pros and cons of PUPSIT as well as the task force findings. 60 minute Online Course November 9th 2023 at 15:30pm IST / 5:00am EDT / 10:00am GMT / 11:00am CET Maik Jornitz Founder and Principal Consultant of BioProcess Resources LLC. Maik Jornitz, Founder and Principal Consultant of BioProcess Resources, is a 35-year veteran of the industry. He is a highly experienced in single-use bioprocesses, aseptic processing, and a subject matter expert in sterilizing grade filtration and filter integrity testing. He has published multiple books, book chapters and over 100 scientific papers on various bioprocessing and facility design topics. He is the former Chair of the PDA Board of Directors and Science Advisory Board, and member of multiple PDA Task Forces, including the EU Annex I response team. He is working member of ASTM E55, an advisory board member of the Biotechnology Industry Council, ICAV, Bondwell and board member of DIANT Pharma and Sunflower Therapeutics. As a faculty member of various training activities, including PDA TRI, he trains members of the industry and regulatory authorities frequently. In his previous roles, he was the CEO of G-CON for 10 years, he worked 26 years for Sartorius, with his last role being the SVP for Global Product and Marketing Management Bioprocess. He received his M.Eng. in Bioengineering at the University of Applied Sciences in Hamburg, Germany and accomplished the PED program at IMD Business School in Lausanne, Switzerland. #Sterilization #sterility #IntegrityTesting #asepticprocessing #RiskAssessment #IntegrityTest #PUPSIT #Annex1 #GMP #pharmaceuticalprocessing #SterilizingGradeFiltration #SterileFilters #FillingSytems #Sterile #Bioprocessing #Biotechnology #BiopharmaCourses https://lnkd.in/ePhtZq-t

GL Sciences InertSustain Cyano In general, the stability and reproducibility of the Cyano phase available in the market are poor. Many batch-to-batch or lot-to-lot reproducibility issues are occurring at many laboratories. The InertSustain Cyano columns were developed to resolve these problems and are designed using the most modern LC column technology available providing them to be extremely inert, stable and reproducible. The InertSustain Cyano columns are highly recommended for all pharmacopeia methods requiring a Cyano phase to be used. (Ex: USP L10) #lcgc #manufacturing #quality #bio #glsciences #lcgcbioanalytical #lcgcbio #glscience #columns #fyp #page #networking #business #marketing #linkedin #linkedinlearning #linkedinmarketing #linkedinpost

BOOK YOUR SEAT FOR THIS 60 MINUTE COURSE ON THURSDAY NOVEMBER 9TH STARTS AT 15.30 IST , 10.00 AM GMT, 11.00 AM CET, 5.00 AM EST Title: PUPSIT – Points to Consider With the publication of the new Annex 1, pre-use post sterilization integrity testing (PUPSIT) of the sterile filter in front of a filling system has been once again emphasized. However, different to previous versions, the regulators added a sentence that it may not be always possible to perform such test and risk assessment tools shall be utilized to find an alternative. PDA and BioPhorum’s task forces on PUPSIT have created a wealth of scientific data; incl. masking studies, data mining, points to consider implementing the test and risk assessment from filter production to end-use. This webinar discusses the pros and cons of PUPSIT as well as the task force findings. Course Instructor: Maik Jornitz Founder and Principal Consultant of BioProcess Resources LLC. Maik Jornitz, Founder and Principal Consultant of BioProcess Resources, is a 35-year veteran of the industry. He is a highly experienced in single-use bioprocesses, aseptic processing, and a subject matter expert in sterilizing grade filtration and filter integrity testing. He has published multiple books, book chapters and over 100 scientific papers on various bioprocessing and facility design topics. He is the former Chair of the PDA Board of Directors and Science Advisory Board, and member of multiple PDA Task Forces, including the EU Annex I response team. He is working member of ASTM E55, an advisory board member of the Biotechnology Industry Council, ICAV, Bondwell and board member of DIANT Pharma and Sunflower Therapeutics. As a faculty member of various training activities, including PDA TRI, he trains members of the industry and regulatory authorities frequently. In his previous roles, he was the CEO of G-CON for 10 years, he worked 26 years for Sartorius, with his last role being the SVP for Global Product and Marketing Management Bioprocess. He received his M.Eng. in Bioengineering at the University of Applied Sciences in Hamburg, Germany and accomplished the PED program at IMD Business School in Lausanne, Switzerland. #Sterilization #sterility #IntegrityTesting #asepticprocessing #RiskAssessment #IntegrityTest #PUPSIT #Annex1 #GMP #pharmaceuticalprocessing #SterilizingGradeFiltration #SterileFilters #FillingSytems #Sterile #Bioprocessing #Biotechnology #BiopharmaCourses https://lnkd.in/ePhtZq-t

Hello everybody, Bacterial induced corrosion cost the global industry billions of dollars every year - if this hits a note with you - I recommend watching the interview with BactiQuant's Aurelija Steffensen from the AMPP conference in the US. Join the conversation - how monitoring bacteria can help safe guarding industrial infrastructure from bacterial induced corrossion. Asset management is a new megatrend in the industry - extending the usefull life of industrial infrastructure - increasing sustainability, and lowering costs. BactiQuant technology is revolutionizing bacterial monitoring under rugged industrial conditions.

#News: Scitara Corporation, has announced an agreement with Waters Corporation (NYSE: WAT). Under the agreement, #Waters has licensed #Scitara’s Digital Lab Exchange DLX™ #cloudplatform to communicate with Waters’ Empower™ #Chromatography #DataSystem and waters_connect™ #LabInformaticsPlatform to bring greater #labconnectivity to an even broader set of laboratory users.   Scitara will provide robust lab ecosystem interoperability through Scitara DLX, the first Integration Platform as a Service (iPaaS) for science. This agreement provides labs with integrated software and infrastructure solutions that help streamline workflows and accelerate product development with the ultimate outcome of bringing new solutions to market faster. This latest agreement with Waters is another key part of Scitara’s partner portfolio of over 20 major strategic vendors in the instrumentation and informatics sectors. Ajit Nagral, Founder and CEO of Scitara commented: "We are delighted to enable customers to gain all the benefits of a connected laboratory that facilitates enriched data-driven decision making. The Scitara DLX is a transformative technology that brings a new integration solution to users of Waters’ chromatography and mass spectrometry instruments and software." See full press release below 👇🏼 💻 Learn more about Scitara Corporation here www.Scitara.com 💻 Learn more about Waters Corporation here https://lnkd.in/efCFT7Bx #RSKTSP #RSKSCITARA #RSKWATERS #RSKJAN24   Anna Marsden-Walker Hannah Steele Kath Darlington Jeff Mazzeo Akash Rai Jagdish Narkhede Alessandro Spada Aimee Chappelow Dave Levy Ravi Kiran Goud Guy Verrastro Kate Wearden Kiran Patel, MBA, CMktr Rowan Moore David Leitham Trish Meek Maria Olteanu Meagan Callis

Have you joined yet ? why not join this free webinar to learn more about the #synbiotic concepts that we have developed in collaboration with Probi AB it might just give you an opportunity to learn more about our Bimuno #prebiotic and #probiotic combination that are synergistically suitable for your #supplements. #microbiome #guthealth #immunehealth #synbiotics